Publication | Closed Access

GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?

Hormonal ContraceptiveCyclophosphamide-induced Ovarian DamagePharmacologyGnrh AgonistsMechanism Of ActionPharmacotherapyEndocrinologyMedicineOvarian HormoneOvarian Cancer